Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Insulin supplemented infant formula

a technology of infant formula and supplementation, which is applied in the direction of drug composition, peptide/protein ingredients, metabolic disorders, etc., can solve the problems of low immunologically recognizable which are attempting to mimic as much as possible breast milk, and the level of active insulin in infant formulas is probably zero, and the level of active insulin in infant formulas is expected to be zero

Inactive Publication Date: 2002-05-30
NUTRINIA LTD
View PDF0 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As shown below, prior art infant formulas, although attempting to mimic as much as possible breast milk, are very low in immunologically recognizable insulin as compared with human milk.
The level of active insulin in these formulas is probably zero, due to the harsh conditions associated with their manufacture.
Although not tested, the level of active insulin in such formulas is expected to be zero due to the harsh conditions associated with their manufacture.
Moreover, it has been shown that exposure to bovine insulin present in fresh cow milk, which differs from human insulin only by three amino acids, may break the tolerance to insulin and lead to autoimmune diabetes (18).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0032] Reference is now made to the following examples, which together with the above descriptions, illustrate the invention in a non limiting fashion.

Materials and Methods

[0033] Milk Samples and insulin measurements:

[0034] Human breast milk samples were collected from mothers between the second and the 30th day after delivery of full term pregnancies. Cow milk samples were taken from pooled fresh commercially available milk. Cow milk formulas were prepared according to manufacturer instructions. All samples were stored in polypropylene tubes at -20.degree. C. Fat-free infranatant were obtained by diluting the milk samples with PBS (10 mM KH.sub.2PO.sub.4, 0.15 M NaCl, pH 7.4) and centrifuged at 100,000 g for 60 min. Clear infranatant were aspirated and stored at -20.degree. C. Insulin concentrations were determined by radioimmunoassay with commercial kit (Bio Data, Sorin) using human insulin as standard.

Experimental Results

[0035] As shown in Table 1 below, insulin concentration is ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Massaaaaaaaaaa
Volumeaaaaaaaaaa
Fractionaaaaaaaaaa
Login to View More

Abstract

An infant formula in a powder or solution form including nutritional components and an insulin supplement. A method of feeding an infant including the steps of dissolving an infant formula powder containing nutritional components and an insulin supplement in water for obtaining a solution including said nutritional components and said insulin supplement and feeding the infant with the solution.

Description

[0001] This application is a continuation in part of U.S. patent application Ser. No. 09 / 701,652 filed in Nov. 30, 2000.FIELD AND BACKGROUND OF THE INVENTION[0002] The present invention relates to an infant formula and, more particularly, to an insulin supplemented infant formula.[0003] Breastfeeding, the natural feeding mode, has multiple beneficial effects on the infant. First, it is known to be the most suitable diet for infant's nutritional requirements. Second, it provides the infant with immune protection against a wide range of infection related diseases (1). Third, as it contains active insulin molecules it protects the infant against the development of Type-1 diabetes (2-3). Fourth, insulin present in milk enhances small intestinal growth and development (4).[0004] Type-1 diabetes, which is insulin dependent diabetes mellitus (IDDM), is the consequence of progressive autoimmune pancreatic .beta. cell destruction during an initially asymptomatic period that may extend many y...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A23L1/305A23L33/00A61K9/00A61K9/14A61K38/28A61P3/10
CPCA23L1/296A23L1/3053A23V2002/00A61K9/0095A61K9/14A61K38/28Y10S514/866A23V2250/30A23V2250/70A23V2250/156A23V2250/06A23V2250/1882A23L33/40A23L33/18A61P3/10
Inventor SHEHADEH, NAIM
Owner NUTRINIA LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products